Hyaluronic Acid-Based Drug Delivery Systems for Cancer Therapy DOI Creative Commons
Ekaterina Pashkina, М. В. Быкова,

M. T. Berishvili

et al.

Cells, Journal Year: 2025, Volume and Issue: 14(2), P. 61 - 61

Published: Jan. 7, 2025

In recent years, hyaluronic acid (HA) has attracted increasing attention as a promising biomaterial for the development of drug delivery systems. Due to its unique properties, such high biocompatibility, low toxicity, and modifiability, HA is becoming basis creation targeted systems, especially in field oncology. Receptors overexpressed subpopulations cancer cells, one them, CD44, recognized molecular marker stem cells. This review examines role receptors health tumors analyzes existing HA-based systems their use various types cancer. The new will bring opportunities challenges anti-cancer therapy.

Language: Английский

Hyaluronic Acid-Based Drug Delivery Systems for Cancer Therapy DOI Creative Commons
Ekaterina Pashkina, М. В. Быкова,

M. T. Berishvili

et al.

Cells, Journal Year: 2025, Volume and Issue: 14(2), P. 61 - 61

Published: Jan. 7, 2025

In recent years, hyaluronic acid (HA) has attracted increasing attention as a promising biomaterial for the development of drug delivery systems. Due to its unique properties, such high biocompatibility, low toxicity, and modifiability, HA is becoming basis creation targeted systems, especially in field oncology. Receptors overexpressed subpopulations cancer cells, one them, CD44, recognized molecular marker stem cells. This review examines role receptors health tumors analyzes existing HA-based systems their use various types cancer. The new will bring opportunities challenges anti-cancer therapy.

Language: Английский

Citations

1